https://www.pharmaceutical-technology.com/data-insights/shigella-bivalent-vaccine-chongqing-zhifei-biological-products-bacillary-dysentery-shigellosis-likelihood-of-approval/
Shigella (bivalent) vaccine is under clinical development by Chongqing Zhifei Biological Products and currently in Phase III for Bacillary Dysentery...
bivalent vaccinebiological productsshigellachongqingzhifei